Harvard Bioscience Income After Taxes 2010-2025 | HBIO

Harvard Bioscience income after taxes from 2010 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Harvard Bioscience Annual Income After Taxes
(Millions of US $)
2024 $-12
2023 $-3
2022 $-10
2021 $0
2020 $-8
2019 $-5
2018 $-4
2017 $-2
2016 $-4
2015 $-19
2014 $2
2013 $1
2012 $4
2011 $5
2010 $19
2009 $7
Harvard Bioscience Quarterly Income After Taxes
(Millions of US $)
2025-03-31 $-50
2024-12-31 $0
2024-09-30 $-5
2024-06-30 $-3
2024-03-31 $-5
2023-12-31 $-2
2023-09-30 $-1
2023-06-30 $-1
2023-03-31 $1
2022-12-31 $-2
2022-09-30 $-3
2022-06-30 $2
2022-03-31 $-7
2021-12-31 $1
2021-09-30 $0
2021-06-30 $0
2021-03-31 $-1
2020-12-31 $-1
2020-09-30 $-1
2020-06-30 $-2
2020-03-31 $-5
2019-12-31 $1
2019-09-30 $-3
2019-06-30 $0
2019-03-31 $-2
2018-12-31 $3
2018-09-30 $0
2018-06-30 $-1
2018-03-31 $-6
2017-12-31 $0
2017-09-30 $-1
2017-06-30 $-1
2017-03-31 $-1
2016-12-31 $-1
2016-09-30 $-2
2016-06-30 $-1
2016-03-31 $-1
2015-12-31 $-17
2015-09-30 $-1
2015-06-30 $0
2015-03-31 $-1
2014-12-31 $0
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $1
2012-12-31 $3
2012-09-30 $0
2012-06-30 $1
2012-03-31 $1
2011-12-31 $2
2011-09-30 $0
2011-06-30 $1
2011-03-31 $2
2010-12-31 $2
2010-09-30 $13
2010-06-30 $2
2010-03-31 $2
2009-12-31 $4
2009-09-30 $1
2009-06-30 $0
2009-03-31 $2
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.015B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.687B 15.97
Kewaunee Scientific (KEQU) United States $0.107B 7.49